Other · Gland Pharma Ltd
Announcement under Regulation 30 (LODR)-Change in Management
BSE filed 9 Nov 2026, 9:55 am IST
Gland Pharma Ltd closed at ₹3,132.80 −1.15% on 8 Nov.
What the filing saysQuoted from the document. Each line opens the page it is on.
- Appointment of Chief Investment Officer for Gland Pharma International Pte. Ltd (Wholly- owned subsidiary of Gland Pharma Limited)
Summary
A one-line summary, the filing chain and past follow-through are in Pro. The quoted passages above stay free. Compare plans
Gland Pharma Ltd’s recent filings
Sign up free to see Gland Pharma Ltd’s recent filings and follow the company.